The DOI matches its Crossref record; 37 of the 39 references it cites were found in a registry or an index.
Presence of hypochlorite-modified proteins in human atherosclerotic lesions.
Open accessAbstract
Oxidation of LDL may contribute to atherogenesis, though the nature of the in vivo oxidant(s) remains obscure. Myeloperoxidase, the enzyme responsible for hypochlorous acid/hypochlorite (HOCl) production in vivo, is present in active form in human atherosclerotic lesions, and HOCl aggregates and transforms LDL into a high-uptake form for macrophages in vitro. Here we demonstrate HOCl-modified proteins in human lesions using an mAb raised against HOCl-modified LDL that recognizes HOCl-oxidized proteins but does not cross-react with Cu2+-, malondialdehyde-, or 4-hydroxynonenal-modified LDL. This antibody detected significantly more material in advanced atherosclerotic lesions than normal arteries, even though azide and methionine were included during sample work-up to inhibit myeloperoxidase and to scavenge HOCl. The epitope(s) recognized was predominantly cell associated and present in monocyte/macrophages, smooth muscle, and endothelial cells. The intima and cholesterol clefts stained more heavily than the center of the thickened vessels; adventitial staining was apparent in some cases. Immunostaining was also detected in a very early lesion from an accident victim, beside healthy areas that were unreactive. LDL oxidized by HOCl in vitro, but not native LDL, effectively competed with the epitopes in lesions for antibody binding. Density centrifugation of plaque homogenates and Western blot analysis showed that, in the apo B-containing lipoprotein fraction, the mAb recognized protein(s) of molecular mass greater than apo B, similar to those produced during oxidation of LDL with HOCl in vitro. Three major proteins were recognized by the anti-HOCl-modified protein antibody but not by an anti-apo B antibody in the apo B-free fraction. Together, these results demonstrate HOCl-oxidized proteins in human atherosclerotic lesions, implicating this oxidant in LDL modification in vivo.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Macrophage localization in the atherosclerotic plaque leads to detectable MPO activity and products of HOCl oxidation (213, 414).”
From Sources of Vascular Nitric Oxide and Reactive Oxygen Species and Their Regulation (2019) · cites this paper as [414]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Measurement of protein using bicinchoninic acid
Smith, P. K., Krohn, R. I., Hermanson, G. T., Mallia, A. K., Gartner, F. H., Provenzano, M. D., Fujimoto, E. K., Goeke, N. M., Olson, B. J., & Klenk, D. C. (1985) · Analytical Biochemistry · doi:10.1016/0003-2697(85)90442-7 · Cited by 18,482
The pathogenesis of atherosclerosis: a perspective for the 1990s
Ross, R. (1993) · Nature · doi:10.1038/362801a0 · Cited by 10,618
Theory and Practice of Histological Techniques
Bancroft, J. D., & Gamble, M. (1990) · Cited by 6,948
Epstein, F. H., Steinberg, D. I., Parthasarathy, S., Carew, T. E., Khoo, J. C., & Witztum, J. L. (1989) · New England Journal of Medicine · doi:10.1056/nejm198904063201407 · Cited by 6,425
Ylä‐Herttuala, S., Palinski, W., Rosenfeld, M. E., Parthasarathy, S., Carew, T. E., Butler, S. S., Witztum, J. L., & Steinberg, D. H. (1989) · Journal of Clinical Investigation · doi:10.1172/jci114271 · Cited by 1,877
Low density lipoprotein undergoes oxidative modification in vivo.
Palinski, W., Rosenfeld, M. E., Ylä‐Herttuala, S., Gurtner, G. C., Socher, S. S., Butler, S. W., Parthasarathy, S., Carew, T. E., Steinberg, D. H., & Witztum, J. L. (1989) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.86.4.1372 · Cited by 1,514
Rg, G. (1981) · PubMed Central · Cited by 1,314
Stary, H. C., Chandler, A. B., Glagov, S. K., Guyton, J. R., Insull, W., Rosenfeld, M. E., Schaffer, S. A., Schwartz, C. J., Wagner, W. D., & Wissler, R. W. (1994) · Circulation · doi:10.1161/01.cir.89.5.2462 · Cited by 1,313
Autoantibody against oxidised LDL and progression of carotid atherosclerosis
Salonen, J. T., Korpela, H., Salonen, R., Nyyssönen, K., Ylä‐Herttuala, S., Yamamoto, R., Butler, S., Palinski, W., & Witztum, J. L. (1992) · The Lancet · doi:10.1016/0140-6736(92)90926-t · Cited by 1,311
Daugherty, A., Dunn, J. L., Rateri, D. L., & Heinecke, J. W. (1994) · Journal of Clinical Investigation · doi:10.1172/jci117342 · Cited by 1,269
Research works printed but not linked: 1
- Adams, D.O., and T.A. Hamilton. 1992. Macrophages as destructive cells in host defense. In Inflammation: Basic principles and clinical correlates. J.I. Gallin, I.M. Goldstein, and R. Snyderman. Raven Press, New York. 637- 662.
Cited by
Sorted by citations
Role of Oxidative Modifications in Atherosclerosis
Stocker, R., & Keaney, J. F. (2004) · Physiological Reviews · doi:10.1152/physrev.00047.2003 · Cited by 2,651
Self-citationProtein carbonyl groups as biomarkers of oxidative stress
Dalle‐Donne, I., Rossi, R., Giustarini, D., Milzani, A., & Colombo, R. (2003) · Clinica Chimica Acta · doi:10.1016/s0009-8981(03)00003-2 · Cited by 2,352
Myeloperoxidase: friend and foe
Klebanoff, S. J. (2005) · Journal of Leukocyte Biology · doi:10.1189/jlb.1204697 · Cited by 2,282
Fluorescent Chemosensors Based on Spiroring-Opening of Xanthenes and Related Derivatives
Chen, X., Pradhan, T., Wang, F., Kim, J. S., & Yoon, J. (2011) · Chemical Reviews · doi:10.1021/cr200201z · Cited by 1,997
Biochemistry and pathology of radical-mediated protein oxidation
Dean, R. T., Fu, S., Stocker, R., & Davies, M. J. (1997) · Biochemical Journal · doi:10.1042/bj3240001 · Cited by 1,678
Self-citationCarr, A. C., & Frei, B. (1999) · The American Journal of Clinical Nutrition · doi:10.1093/ajcn/69.6.1086 · Cited by 940
Oxysterols and atherosclerosis
Brown, A. J., & Jessup, W. (1999) · Atherosclerosis · doi:10.1016/s0021-9150(98)00196-8 · Cited by 923
Hazen, S. L., & Heinecke, J. W. (1997) · Journal of Clinical Investigation · doi:10.1172/jci119379 · Cited by 842
Myeloperoxidase and Cardiovascular Disease
Nicholls, S. J., & Hazen, S. L. (2005) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/01.atv.0000163262.83456.6d · Cited by 805
Reactive oxygen species in cardiovascular disease
Sugamura, K., & Keaney (2011) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2011.05.004 · Cited by 769
QUANTIFICATION AND SIGNIFICANCE OF PROTEIN OXIDATION IN BIOLOGICAL SAMPLES*
Shacter, E. B. (2000) · Drug Metabolism Reviews · doi:10.1081/dmr-100102336 · Cited by 748
Sugiyama, S., Okada, Y., Sukhova, G. K., Virmani, R., Heinecke, J. W., & Libby, P. (2001) · American Journal Of Pathology · doi:10.1016/s0002-9440(10)64036-9 · Cited by 699
Myeloperoxidase-generated oxidants and atherosclerosis
Podrez, E. A., Abu‐Soud, H. M., & Hazen, S. L. (2000) · Free Radical Biology and Medicine · doi:10.1016/s0891-5849(00)00229-x · Cited by 607
Sources of Vascular Nitric Oxide and Reactive Oxygen Species and Their Regulation
Tejero, J., Shiva, S., & Gladwin, M. T. (2019) · Physiological Reviews · doi:10.1152/physrev.00036.2017 · Cited by 541
Myeloperoxidase: Molecular Mechanisms of Action and Their Relevance to Human Health and Disease
van der Veen, B. S., de Winther, M. P. J., & Heeringa, P. (2009) · Antioxidants and Redox Signaling · doi:10.1089/ars.2009.2538 · Cited by 530
Myeloperoxidase-generated reactive nitrogen species convert LDL into an atherogenic form in vitro
Podrez, E. A., Schmitt, D. C., Hoff, H. F., & Hazen, S. L. (1999) · Journal of Clinical Investigation · doi:10.1172/jci5549 · Cited by 500
Hypochlorous Acid Oxygenates the Cysteine Switch Domain of Pro-matrilysin (MMP-7)
Fu, X., Kassim, S. Y., Parks, W. C., & Heinecke, J. W. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m106958200 · Cited by 482
Heinecke, J. W. (1998) · Atherosclerosis · doi:10.1016/s0021-9150(98)00173-7 · Cited by 462
Stable markers of oxidant damage to proteins and their application in the study of human disease
Davies, M. J., Fu, S., Wang, H., & Dean, R. T. (1999) · Free Radical Biology and Medicine · doi:10.1016/s0891-5849(99)00206-3 · Cited by 461
Podrez, E. A., Febbraio, M., Sheibani, N., Schmitt, D. C., Silverstein, R. L., Hajjar, D. P., Cohen, P. A., Frazier, W. A., Hoff, H. F., & Hazen, S. L. (2000) · Journal of Clinical Investigation · doi:10.1172/jci8574 · Cited by 461
Bergt, C., Pennathur, S., Fu, X., Byun, J., O'Brien, K., McDonald, T. O., Singh, P., Anantharamaiah, G. M., Chait, A., Brunzell, J., et al. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0405292101 · Cited by 454
Podrez, E. A., Poliakov, E., Shen, Z., Zhang, R., Deng, Y., Sun, M., Finton, P. J., Shan, L., Gugiu, B. G., Fox, P. L., et al. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m203318200 · Cited by 461
Detection, identification, and quantification of oxidative protein modifications
Hawkins, C. L., & Davies, M. J. (2019) · Journal of Biological Chemistry · doi:10.1074/jbc.rev119.006217 · Cited by 449
Myeloperoxidase: a target for new drug development?
Malle, E., Furtmüller, P. G., Sattler, W., & Obinger, C. (2007) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0707358 · Cited by 411
Self-citationHayden, M. R., & Tyagi, S. C. (2004) · Nutrition & Metabolism · doi:10.1186/1743-7075-1-10 · Cited by 397
High-Density Lipoprotein Function, Dysfunction, and Reverse Cholesterol Transport
Fisher, E. A. A., Feig, J. E., Hewing, B., Hazen, S. L., & Smith, J. D. (2012) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/atvbaha.112.300133 · Cited by 404
Biomarkers of myeloperoxidase-derived hypochlorous acid
Winterbourn, C. C., & Kettle, A. J. (2000) · Free Radical Biology and Medicine · doi:10.1016/s0891-5849(00)00204-5 · Cited by 390
Keshari, R. S., Jyoti, A., Dubey, M., Kothari, N., Kohli, M., Bogra, J., Barthwal, M. K., & Dikshit, M. (2012) · PLoS ONE · doi:10.1371/journal.pone.0048111 · Cited by 408
Anderson, M. M., Hazen, S. L., Hsu, F., & Heinecke, J. W. (1997) · Journal of Clinical Investigation · doi:10.1172/jci119176 · Cited by 392
Oxidation of LDL by Myeloperoxidase and Reactive Nitrogen Species
Carr, A. C., McCall, M. R., & Frei, B. B. (2000) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/01.atv.20.7.1716 · Cited by 392
Thomas, S. R., Witting, P. K., & Drummond, G. R. (2008) · Antioxidants & Redox Signaling · doi:10.1089/ars.2008.2027 · Cited by 383
Sluimer, J. C., Kolodgie, F. D., Bijnens, A. P., Maxfield, K., Pacheco, E., Kutys, B., Duimel, H., Frederik, P. M., van Hinsbergh, V. W. M., Virmani, R., et al. (2009) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2008.12.056 · Cited by 367
Leeuwenburgh, C., RASMUSSEN, J. E., Hsu, F., Mueller, D. M., Pennathur, S., & Heinecke, J. W. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.6.3520 · Cited by 361
Atherosclerosis and arteriosclerosis in chronic renal failure
London, G. M., & Drüeke, T. B. (1997) · Kidney International · doi:10.1038/ki.1997.233 · Cited by 351
Myeloperoxidase in kidney disease
Malle, E., Buch, T., & Gröne, H. (2003) · Kidney International · doi:10.1046/j.1523-1755.2003.00336.x · Cited by 353
Self-citationAn update on the lipid nephrotoxicity hypothesis
Ruan, X. Z., Varghese, Z., & Moorhead, J. F. (2009) · Nature Reviews Nephrology · doi:10.1038/nrneph.2009.184 · Cited by 349
Neutrophils aggravate acute liver injury during obstructive cholestasis in bile duct–ligated mice
Gujral, J., Farhood, A., Bajt, M., & Jaeschke, H. (2003) · Hepatology · doi:10.1053/jhep.2003.50341 · Cited by 353
Pattison, D. I., & Davies, M. J. (2006) · Biochemistry · doi:10.1021/bi060348s · Cited by 338
The Role of Myeloperoxidase in Biomolecule Modification, Chronic Inflammation, and Disease
Davies, M. J., & Hawkins, C. L. (2020) · Antioxidants & Redox Signaling · doi:10.1089/ars.2020.8030 · Cited by 332
Oxidative stress and cardiovascular disease: Novel tools give (free) radical insight
Fearon, I. M., & Faux, S. P. (2009) · Journal of Molecular and Cellular Cardiology · doi:10.1016/j.yjmcc.2009.05.013 · Cited by 334
Increased atherosclerosis in myeloperoxidase-deficient mice
Brennan, M., Anderson, M. M., Shih, D. M., Qu, X.-D., Wang, X., Mehta, A., Lim, L. L., Shi, W., Hazen, S. L., Jacob, J. S., et al. (2001) · Journal of Clinical Investigation · doi:10.1172/jci8797 · Cited by 321
Duan, C., Won, M., Verwilst, P., Xu, J., Kim, H. S., Zeng, L., & Kim, J. S. (2019) · Analytical Chemistry · doi:10.1021/acs.analchem.9b00224 · Cited by 320
Living with a Killer: The Effects of Hypochlorous Acid on Mammalian Cells
Pullar, J. M., Vissers, M. C. M., & Winterbourn, C. C. (2000) · IUBMB Life · doi:10.1080/713803731 · Cited by 316
Stadler, N., Lindner, R. A., & Davies, M. J. (2004) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/01.atv.0000124892.90999.cb · Cited by 310
Klebanoff, S. J. (1999) · Proceedings of the Association of American Physicians · doi:10.1111/paa.1999.111.5.383 · Cited by 308
Hawkins, C. L., & Davies, M. J. (1998) · Biochemical Journal · doi:10.1042/bj3320617 · Cited by 305
Upston, J. M., Terentis, A. C., & Stocker, R. (1999) · The FASEB Journal · doi:10.1096/fasebj.13.9.977 · Cited by 302
Self-citationYoshida, H., & Kisugi, R. (2010) · Clinica Chimica Acta · doi:10.1016/j.cca.2010.08.038 · Cited by 289
Choi, D., Pennathur, S., Perier, C., Tieu, K., Teismann, P., Wu, D.-C., Jackson-Lewis, V. R., Vila, M., Vonsattel, J., Heinecke, J. W., et al. (2005) · Journal of Neuroscience · doi:10.1523/jneurosci.0970-05.2005 · Cited by 286
Winterbourn, C. C., Vissers, M. C. M., & Kettle, A. J. (2000) · Current Opinion in Hematology · doi:10.1097/00062752-200001000-00010 · Cited by 278
Shepherd, J., Hilderbrand, S. A., Waterman, P. R., Heinecke, J. W., Weissleder, R., & Libby, P. (2007) · Chemistry & Biology · doi:10.1016/j.chembiol.2007.10.005 · Cited by 265
Recent progress in the development of fluorescent probes for the detection of hypochlorous acid
Zhang, Y., Liu, Y. M., Feng, X., & Zhao, B. (2016) · Sensors and Actuators B Chemical · doi:10.1016/j.snb.2016.08.066 · Cited by 264
Neutrophils in the innate immune response.
Kobayashi, S. D., Voyich, J. M., Burlak, C., & DeLeo, F. R. (2005) · PubMed · Cited by 260
Human neutrophils employ chlorine gas as an oxidant during phagocytosis.
Hazen, S. L., Hsu, F., Mueller, D. M., Crowley, J., & Heinecke, J. W. (1996) · Journal of Clinical Investigation · doi:10.1172/jci118914 · Cited by 258
Interactions Between Nitric Oxide and Lipid Oxidation Pathways: Implications for Vascular Disease
O’Donnell, V. B., & Freeman, B. A. (2001) · Circulation Research · doi:10.1161/01.res.88.1.12 · Cited by 257
Evidence for roles of radicals in protein oxidation in advanced human atherosclerotic plaque
Fu, S., Davies, M. J., Stocker, R., & Dean, R. T. (1998) · Biochemical Journal · doi:10.1042/bj3330519 · Cited by 256
Self-citationThe Roles of Neutrophil-Derived Myeloperoxidase (MPO) in Diseases: The New Progress
Lin, W. C., Chen, H., Chen, X., & Guo, C. (2024) · Antioxidants · doi:10.3390/antiox13010132 · Cited by 290
Öörni, K., Pentikäinen, M. O., Ala-Korpela, M., & Kovanen, P. T. (2000) · Journal of Lipid Research · doi:10.1016/s0022-2275(20)31964-7 · Cited by 252
Biological reactivity and biomarkers of the neutrophil oxidant, hypochlorous acid
Winterbourn, C. C. (2002) · Toxicology · doi:10.1016/s0300-483x(02)00286-x · Cited by 247
Chen, X., Lee, K.-A., Ha, E.-M., Lee, K. M., Seo, Y. Y., Choi, H. K., Kim, H. N., Kim, M. J., Cho, C.-S., Lee, S. Y., et al. (2011) · Chemical Communications · doi:10.1039/c1cc10589b · Cited by 246
Malle, E., Waeg, G., Schreiber, R., Gröne, E. F., Sattler, W., & Gröne, H. (2000) · European Journal of Biochemistry · doi:10.1046/j.1432-1327.2000.01498.x · Cited by 245
Self-citationCell signaling by reactive nitrogen and oxygen species in atherosclerosis
Patel, R. P., Moellering, D. R., Murphy-Ullrich, J. E., Jo, H., Beckman, J. S., & Darley-Usmar, V. M. (2000) · Free Radical Biology and Medicine · doi:10.1016/s0891-5849(00)00235-5 · Cited by 243
Ulfig, A., & Leichert, L. I. (2021) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-020-03591-y · Cited by 239
Biosynthesis, processing, and sorting of human myeloperoxidase
Hansson, M., Olsson, I., & Nauseef, W. M. (2005) · Archives of Biochemistry and Biophysics · doi:10.1016/j.abb.2005.08.009 · Cited by 240
Hazen, S. L., Hsu, F. F., Duffin, K., & Heinecke, J. W. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.38.23080 · Cited by 221
Oxidative risk for atherothrombotic cardiovascular disease
Leopold, J. A., & Loscalzo, J. (2009) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2009.09.009 · Cited by 218
Pattison, D. I., & Davies, M. J. (2004) · Biochemistry · doi:10.1021/bi035946a · Cited by 209
Myeloperoxidase, modified lipoproteins, and atherogenesis
Nicholls, S. J., & Hazen, S. L. (2008) · Journal of Lipid Research · doi:10.1194/jlr.r800086-jlr200 · Cited by 211
Eiserich, J. P., Patel, R. P., & O’Donnell, V. B. (1998) · Molecular Aspects of Medicine · doi:10.1016/s0098-2997(99)00002-3 · Cited by 211
Hawkins, C. L., & Davies, M. J. (1999) · Biochemical Journal · doi:10.1042/bj3400539 · Cited by 201
Baldus, S. E., Rudolph, V., Roiss, M., Ito, W. D., Rudolph, T. K., Eiserich, J. P., Sydow, K., Lau, D., Szöcs, K., Klinke, A., et al. (2006) · Circulation · doi:10.1161/circulationaha.105.590083 · Cited by 198
Pathophysiological role of neutrophils in acute myocardial infarction
Carbone, F., Nencioni, A., Mach, F., Vuilleumier, N., & Montecucco, F. (2013) · Thrombosis and Haemostasis · doi:10.1160/th13-03-0211 · Cited by 204
Glutathione-Related Antioxidant Defenses in Human Atherosclerotic Plaques
Lapenna, D., de Gioia, S., Ciofani, G., Mezzetti, A., Ucchino, S., Calafiore, A. M., Napolitano, A. M., Ilio, C. D., & Cuccurullo, F. (1998) · Circulation · doi:10.1161/01.cir.97.19.1930 · Cited by 197
Myeloperoxidase: A Leukocyte-Derived Protagonist of Inflammation and Cardiovascular Disease
Nußbaum, C., Klinke, A., Adam, M., Baldus, S. E., & Sperandio, M. (2012) · Antioxidants and Redox Signaling · doi:10.1089/ars.2012.4783 · Cited by 199
Nitric Oxide Modulates the Catalytic Activity of Myeloperoxidase
Abu‐Soud, H. M., & Hazen, S. L. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.275.8.5425 · Cited by 194
Thukkani, A. K., McHowat, J., Hsu, F.-F., Brennan, M.-L., Hazen, S. L., & Ford, D. A. (2003) · Circulation · doi:10.1161/01.cir.0000104564.01539.6a · Cited by 194
Guo, Z. J., Niu, H. X., Hou, F. F., Zhang, L., Fu, N., Nagai, R., Lu, X., Chen, B. H., Shan, Y., Tian, J. W., et al. (2008) · Antioxidants and Redox Signaling · doi:10.1089/ars.2007.1999 · Cited by 193
New insights on oxidative stress in the artery wall
STOCKER, R., & KEANEY, J. F. (2005) · Journal of Thrombosis and Haemostasis · doi:10.1111/j.1538-7836.2005.01370.x · Cited by 188
Self-citationS100A8 and S100A9 in Human Arterial Wall
McCormick, M. M., Rahimi, F., Bobryshev, Y. V., Gaus, K., Zreiqat, H., Cai, H., Lord, R. S. A., & Geczy, C. L. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m509442200 · Cited by 186
Hu, J. J., Wong, N.-K., Gu, Q., Bai, X., Ye, S., & Yang, D. (2014) · Organic Letters · doi:10.1021/ol501496n · Cited by 186
Miller, Y. I., Altamentova, S. M., & Shaklai, N. (1997) · Biochemistry · doi:10.1021/bi970258a · Cited by 185
Malle, E., Marsche, G., Arnhold, J., & Davies, M. J. (2006) · Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids · doi:10.1016/j.bbalip.2006.03.024 · Cited by 184
Self-citationLiu, S. X., Hou, F. F., Guo, Z. J., Nagai, R., Zhang, W. R., Liu, Z., Zhou, Z. M., Zhou, M., Xie, D., Wang, G. B., et al. (2006) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/01.atv.0000214960.85469.68 · Cited by 184
Annema, W., & von Eckardstein, A. (2013) · Circulation Journal · doi:10.1253/circj.cj-13-1025 · Cited by 185
Noguchi, N., & Niki, E. (2000) · Free Radical Biology and Medicine · doi:10.1016/s0891-5849(00)00256-2 · Cited by 182
The Oxidation of Lipoproteins by Monocytes-Macrophages
Chisolm, G. M., Hazen, S. L., Fox, P. L., & Cathcart, M. K. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.37.25959 · Cited by 174
Anti-Infective Protective Properties of S100 Calgranulins
Hsu, K., Champaiboon, C., Guenther, B. D., Sorenson, B. S., Khammanivong, A., Ross, K. F., Geczy, C. L., & Herzberg, M. C. (2009) · Anti-Inflammatory & Anti-Allergy Agents in Medicinal Chemistry · doi:10.2174/187152309789838975 · Cited by 178
Chen, X., Lee, K.-A., Ren, X., Ryu, J., Kim, G., Ryu, J.-H., Lee, W., & Yoon, J. (2016) · Nature Protocols · doi:10.1038/nprot.2016.062 · Cited by 170
Expression of Human Myeloperoxidase by Macrophages Promotes Atherosclerosis in Mice
McMillen, T. S., Heinecke, J. W., & LeBoeuf, R. C. (2005) · Circulation · doi:10.1161/circulationaha.104.516278 · Cited by 168
Gujral, J. S., Liu, J., Farhood, A. I., Hinson, J., & Jaeschke, H. (2004) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.00318.2003 · Cited by 167
Dialysis‐Induced Oxidative Stress: Biological Aspects, Clinical Consequences, and Therapy
Descamps‐Latscha, B., Drüeke, T. B., & Witko‐Sarsat, V. (2001) · Seminars in Dialysis · doi:10.1046/j.1525-139x.2001.00052.x · Cited by 162
Mitochondria and lysosome-targetable fluorescent probes for HOCl: recent advances and perspectives
Ren, M., Zhou, K., He, L., & Lin, W. (2018) · Journal of Materials Chemistry B · doi:10.1039/c7tb03337k · Cited by 159
Molecular action of vitamin E in lipoprotein oxidation:
Thomas, S. R., & Stocker, R. (2000) · Free Radical Biology and Medicine · doi:10.1016/s0891-5849(00)00236-7 · Cited by 159
Self-citationHypochlorous acid as a precursor of free radicals in living systems
Panasenko, O. M., Gorudko, I. V., & Av, S. (2013) · Biochemistry (Moscow) · doi:10.1134/s0006297913130075 · Cited by 159
Hu, J. J., Wong, N.-K., Lu, M.-Y., Chen, X., Ye, S., Zhao, A. Q., Gao, P., Kao, R. Y. T., Shen, J., & Yang, D. (2016) · Chemical Science · doi:10.1039/c5sc03855c · Cited by 156
On the Role of Vitamin C and Other Antioxidants in Atherogenesis and Vascular Dysfunction
Frei, B. B. (1999) · Proceedings of The Society for Experimental Biology and Medicine · doi:10.1046/j.1525-1373.1999.d01-136.x · Cited by 158
Spickett, C. M., Jerlich, A., Panasenko, O. M., Arnhold, J., Pitt, A. R., Stelmaszyńska, T., & Schaur, R. J. (2000) · Acta Biochimica Polonica · doi:10.18388/abp.2000_3944 · Cited by 154
Dou, K., Fu, Q., Chen, G., Yu, F., Liu, Y., Cao, Z., Li, G., Zhao, X., Xia, L., Chen, L., et al. (2017) · Biomaterials · doi:10.1016/j.biomaterials.2017.04.024 · Cited by 153
Zelvyté, I., Dominaitiene, R., Crisby, M., & Janciauskiene, S. M. (2002) · Pharmacological Research · doi:10.1006/phrs.2001.0922 · Cited by 152
Jacob, J. S., Cistola, D. P., Hsu, F., Muzaffar, S., Mueller, D. M., Hazen, S. L., & Heinecke, J. W. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.33.19950 · Cited by 150
Metadata
- Authors
- Hazell, L. J., Arnold, L., Flowers, D., Waeg, G., Malle, E., & Stocker, R.
- Affiliations
- The Heart Research Institute (AU)
- The University of Sydney (AU)
- University of Graz (AT)
- ORCID
- Venue
- Journal of Clinical Investigation
- Published
- 1996-03-15
- Volume
- 97
- Issue
- 6
- Pages
- 1535-1544
- ISSN
- 0021-9738 (ISSN-L)
- PMC
- PMC507214
- OpenAlex
- W2118480498
- Cited by
- 592
- References
- 39
- Citations by year
- 2026: 3 · 2025: 4 · 2024: 14 · 2023: 14 · 2022: 19 · 2021: 12 · 2020: 18 · 2019: 20 · 2018: 26 · 2017: 16 · 2016: 12 · 2015: 17 · 2014: 15 · 2013: 13 · 2012: 16
- FWCI
- 11.70
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- Journal of Clinical Investigation (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Heart Foundation of Australia
- Austrian Science Fund
- Medical Research Council
- National Health and Medical Research Council
- Topics
- Life Sciences › Immunology and Microbiology › Immunology › Atherosclerosis and Cardiovascular Diseases
- Life Sciences › Immunology and Microbiology › Immunology › Neutrophil, Myeloperoxidase and Oxidative Mechanisms
- Health Sciences › Medicine › Physiology (medical) › Nitric Oxide and Endothelin Effects
- Keywords
- hypochlorite, myeloperoxidase, atherosclerosis, LDL oxidation, oxidized LDL, atherosclerotic plaque, macrophages, smooth muscle cells, endothelial cells, oxidizing agents, atherogenesis
- MeSH terms
- Arteriosclerosis, Humans, Hypochlorous Acid, Immunohistochemistry, Lipoproteins, LDL, Oxidation-Reduction, Proteins
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review